# US 2026/0137090 A1 · Viral active and/or anti-microbial inks and coatings

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0137090 A1
- Document ID: US20260137090A1
- Status: Published application
- Kind: A1
- Application number: 19/447,229
- Filed: 2026-01-13
- Published: 2026-05-21
- Earliest claimed: 2020-05-14
- Assignees: Graphene Composites Ltd
- Applicants: Graphene Composites Limited
- Inventors: Sandy Winthrop CHEN; Stephen DEVINE
- Web page: https://patentgrep.com/patent/US20260137090A1

## CPC

- A01N 63/40: Viruses, e.g. bacteriophages
- C09D 11/037: characterised by the pigment
- A01N 25/10: Macromolecular compounds
- A01N 35/02: containing aliphatically bound aldehyde or keto groups, or thio analogues thereof; Derivatives thereof, e.g. acetals
- A01N 35/04: containing aldehyde or keto groups, or thio analogues thereof, directly attached to an aromatic ring system, e.g. acetophenone; Derivatives thereof, e.g. acetals
- A01N 59/00: Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
- A01N 59/16: Heavy metals; Compounds thereof
- A01P 1/00: Disinfectants; Antimicrobial compounds or mixtures thereof
- A61P 31/04: Antibacterial agents
- A61P 31/12: Antivirals
- C08K 9/02: Ingredients treated with inorganic substances
- C09D 5/14: Paints containing biocides, e.g. fungicides, insecticides or pesticides (C09D5/16 takes precedence)
- C09D 5/1687: {Use of special additives}
- C09D 7/40: Additives
- C09D 7/61: inorganic
- C09D 7/62: modified by treatment with other compounds
- C09D 7/63: organic
- C09D 7/67: {Particle size smaller than 100 nm}
- C09D 11/03: characterised by features other than the chemical nature of the binder
- C09D 11/10: based on artificial resins
- C09D 11/324: containing carbon black
- C09D 11/38: characterised by non-macromolecular additives other than solvents, pigments or dyes
- D06M 11/74: with carbon or graphite; with carbides; with graphitic acids or their salts
- D06M 15/00: Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment (D06M10/00, D06M14/00 take precedence; {treatment with inorganic polyphosphates D06M11/72})
- D06M 23/08: Processes in which the treating agent is applied in powder or granular form (adhesives for multi-layer textile fabrics D06M17/00)
- D06P 5/30: Ink jet printing
- C08K 3/042: {Graphene or derivatives, e.g. graphene oxides}
- C08K 5/132: Phenols containing keto groups {, e.g. benzophenones}
- C08K 2003/0806: {Silver}
- C08K 2003/085: {Copper}
- Y02A 50/30: Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- C09D: COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR (cosmetics A61K; processes for applying liquids or other fluent materials to surfaces, in general, B05D; staining wood B27K5/02; glazes or vitreous enamels C03C; natural resins, French polish, drying-oils, driers, turpentine, per se, C09F; polishing compositions other than French polish, ski waxes C09G; adhesives or use of materials as adhesives C09J; materials for sealing or packing joints or covers C09K3/10; materials for stopping leaks C09K3/12; processes for the electrolytic or electrophoretic production of coatings C25D)
- A01P: BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C08K: Use of inorganic or non-macromolecular organic substances as compounding ingredients (paints, inks, varnishes, dyes, polishes, adhesives C09)
- D06M: TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06P: DYEING OR PRINTING TEXTILES; DYEING LEATHER, FURS OR SOLID MACROMOLECULAR SUBSTANCES IN ANY FORM
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

An ink comprises (i) a carrier; (ii) graphene and/or graphene oxide particles dispersed in the carrier; and (iii) a viral active and/or anti-microbial component adhered to the graphene and/or graphene oxide particles.

## Claims

### Claim 1

An ink for providing a viral active and/or anti-microbial coating to a substrate, comprising:
(i) a carrier;
(ii) graphene and/or graphene oxide particles dispersed in the carrier; and
(iii) a viral active and/or anti-microbial component adhered to the graphene and/or graphene oxide particles.

### Claim 2 (depends on 1)

The ink according to claim 1, wherein the viral active and/or anti-microbial component comprises metal ions, metal nanoparticles, curcumin and/or hypericin.

### Claim 3 (depends on 2)

The ink according to claim 2, wherein the viral active and/or anti-microbial component comprises metal nanoparticles and wherein the metal nanoparticles have a particle size of 1 to 100 nm.

### Claim 4 (depends on 1)

The ink according to claim 1, wherein the graphene and/or graphene oxide particles have a surface coverage of the viral active and/or anti-microbial component of from 5% to 60%.

### Claim 5 (depends on 1)

The ink according to claim 1, wherein the graphene and/or graphene oxide particles and viral active and/or anti-microbial component combined have a weight content of from 1% to 60% wt % viral active and/or anti-microbial component.

### Claim 6 (depends on 1)

The ink according to claim 1, wherein the surfaces and/or edges of the graphene and/or graphene oxide particles are functionalised with the viral active and/or anti-microbial component.

### Claim 7 (depends on 1)

The ink according to claim 1, wherein the graphene and/or graphene oxide particles are functionalised particles and comprise functional groups selected from thiols, hydroxyl, carboxyl, epoxyl and/or carbonyl groups.

### Claim 8 (depends on 7)

The ink according to claim 7, wherein the ink comprises graphene particles; and wherein the graphene particles are functionalised with oxygen-containing functional groups and have an oxygen content of from 10 to 30%.

### Claim 9 (depends on 1)

The ink according to claim 1, wherein the ink comprises graphene oxide particles; and wherein the graphene oxide particles have an oxygen content of from 24 to 40%.

### Claim 10 (depends on 1)

The ink according to claim 1, wherein the ink further comprises (i) a binder, optionally selected from cellulose acetate, cellulose acetate butyrate, diethyl phthalate, poly(methyl methacrylate), poly(ethylene)glycol and polyvinylpyrrolidone (PVP); (ii) a drying agent; and/or (iii) a rheology modifier.

### Claim 11 (depends on 1)

The ink according to claim 1, wherein the concentration of the combined graphene and/or graphene oxide particles and viral active and/or anti-microbial component in the carrier is from 0.05 mg/ml to 10 mg/ml.

### Claim 12 (depends on 1)

The ink according to claim 1, wherein the viral active and/or anti-microbial component comprises a capping agent.

### Claim 13 (depends on 12)

The ink according to claim 12, wherein the viral active and/or anti-microbial component comprises capped silver nanoparticles.

### Claim 14

A viral active and/or anti-microbial article comprising:
a substrate; and
a coating provided on the substrate,
wherein the coating comprises:
(i) graphene and/or graphene oxide particles; and
(ii) a viral active and/or anti-microbial component adhered to the graphene and/or graphene oxide particles.

### Claim 15 (depends on 14)

The article according to claim 14, wherein the substrate comprises polyester, polypropylene, a textile or a cellulosic material.

### Claim 16 (depends on 14)

The article according to claim 14,
wherein the article is a filter and the substrate is a filtration membrane provided in the filter to filter particulates passing through the filter; and
optionally wherein the coating is provided on at least one surface of the filtration membrane.

### Claim 17 (depends on 14)

The article according to claim 14,
wherein the filter comprises at least one fine filtration membrane having a filtration efficiency of at least 95% for particles having a size of 0.3 μm; and
wherein the filtration membrane comprising the graphene and/or graphene oxide particles and a viral active and/or anti-microbial component is a coarse filtration membrane, relative to the fine filtration membrane.

### Claim 18

A method of producing an ink, comprising:
(a) combining graphene and/or graphene oxide particles with a viral active and/or anti-microbial component to adhere t, he viral active and/or anti-microbial component to the graphene and/or graphene oxide particles; and
(b) dispersing the combined graphene and/or graphene oxide particles and viral active and/or anti-microbial component in a carrier.

### Claim 19 (depends on 18)

The method according to claim 18, wherein combining graphene and/or graphene oxide particles with a viral active and/or anti-microbial component comprises dispersing the graphene and/or graphene oxide particles and the viral active and/or anti-microbial component in a carrier, followed by adhering the viral active and/or anti-microbial component to the graphene and/or graphene oxide particles.

### Claim 20 (depends on 19)

The method according to claim 19, wherein dispersing the graphene and/or graphene oxide particles and the viral active and/or anti-microbial component in a carrier comprises dispersing graphene and/or graphene oxide particles in a carrier, followed by addition of the viral active and/or anti-microbial component to the carrier.

### Claim 21 (depends on 19)

The method according to claim 19, wherein a viral active and/or anti-microbial precursor is added to the carrier and the method comprises converting the precursor into the viral active and/or anti-microbial component in situ.

### Claim 22 (depends on 21)

The method according to claim 21, wherein the graphene is a functionalised graphene, and the step (a) comprises combining functionalised graphene and/or graphene oxide with a viral active and/or anti-microbial precursor, followed by addition of a reducing agent to reduce the viral active and/or anti-microbial precursor to form the viral active and/or anti-microbial component.

### Claim 23 (depends on 18)

The method according to claim 18, wherein the viral active and/or anti-microbial component is a metal nanoparticle, and the metal nanoparticle is combined with graphene and/or graphene oxide particles in the carrier.

### Claim 24 (depends on 18)

The method according to claim 18, further comprising the step of functionalising the graphene and/or graphene oxide particles prior to step (a), optionally wherein the step of functionalising the graphene and/or graphene oxide particles comprises functionalising the graphene and/or graphene oxide particles with at least one functional group selected from thiol, hydroxyl, carboxyl, epoxyl and/or carbonyl groups.

### Claim 25 (depends on 18)

The method according to claim 18, wherein the viral active and/or anti-microbial component is provided with a capping agent.
